Goldman Sachs Group set a €70.00 ($81.40) price objective on Gerresheimer (ETR:GXI) in a report issued on Thursday. The brokerage currently has a neutral rating on the stock.

Several other brokerages have also issued reports on GXI. Kepler Capital Markets set a €65.00 ($75.58) price target on Gerresheimer and gave the company a sell rating in a research note on Thursday, July 12th. equinet set a €69.00 ($80.23) price target on Gerresheimer and gave the company a neutral rating in a research note on Thursday, July 12th. Commerzbank set a €68.00 ($79.07) price target on Gerresheimer and gave the company a neutral rating in a research note on Thursday, July 12th. JPMorgan Chase & Co. set a €79.40 ($92.33) price target on Gerresheimer and gave the company a neutral rating in a research note on Thursday, July 12th. Finally, Hauck & Aufhaeuser set a €52.50 ($61.05) price target on Gerresheimer and gave the company a sell rating in a research note on Monday, July 16th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock has a consensus rating of Hold and an average target price of €71.67 ($83.33).

Shares of GXI opened at €61.50 ($71.51) on Thursday. Gerresheimer has a 12-month low of €59.97 ($69.73) and a 12-month high of €78.25 ($90.99).

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Recommended Story: Penny Stocks, What You Need To Know

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.